HLS Therapeutics (HLTRF) Q4 2025 Earnings

Nov 13Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.14
-0.11
-0.09
-0.06

Details

Expected EPS
-0.0623
Actual EPS
-0.12
Surprise EPS
-0.06
Surprise Percent
-92.62%

Description

⁨HLS Therapeutics⁩ (⁦HLTRF⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts